343 related articles for article (PubMed ID: 37223276)
1. Lipid Nanocarrier-Based Drug Delivery Systems: Therapeutic Advances in the Treatment of Lung Cancer.
Kim SJ; Puranik N; Yadav D; Jin JO; Lee PCW
Int J Nanomedicine; 2023; 18():2659-2676. PubMed ID: 37223276
[TBL] [Abstract][Full Text] [Related]
2. Cancer chemotherapy with lipid-based nanocarriers.
Liu D; Zhang N
Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
[TBL] [Abstract][Full Text] [Related]
3. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
[TBL] [Abstract][Full Text] [Related]
4. Lipid-based Nanocarriers for Cancer and Tumor Treatment.
Ansari MT; Ramlan TA; Jamaluddin NN; Zamri N; Salfi R; Khan A; Sami F; Majeed S; Hasnain MS
Curr Pharm Des; 2020; 26(34):4272-4276. PubMed ID: 32693760
[TBL] [Abstract][Full Text] [Related]
5. Lipid based nanocarriers: a translational perspective.
Mishra DK; Shandilya R; Mishra PK
Nanomedicine; 2018 Oct; 14(7):2023-2050. PubMed ID: 29944981
[TBL] [Abstract][Full Text] [Related]
6. Advances and Implications in Nanotechnology for Lung Cancer Management.
Sarkar S; Osama K; Jamal QMS; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Akhtar S
Curr Drug Metab; 2017; 18(1):30-38. PubMed ID: 27842486
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
Siafaka PI; Mutlu G; Okur NÜ
Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
[TBL] [Abstract][Full Text] [Related]
8. Nanocarrier-Mediated Drug Delivery via Inhalational Route for Lung Cancer Therapy: A Systematic and Updated Review.
Ara N; Hafeez A
AAPS PharmSciTech; 2024 Feb; 25(3):47. PubMed ID: 38424367
[TBL] [Abstract][Full Text] [Related]
9. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
10. Design strategy and research progress of multifunctional nanoparticles in lung cancer therapy.
Min SH; Lei W; Jun CJ; Yan ZS; Guang YX; Tong Z; Yong ZP; Hui LZ; Xing H
Expert Opin Investig Drugs; 2023; 32(8):723-739. PubMed ID: 37668152
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.
Kumar R; Mehta P; Shankar KR; Rajora MAK; Mishra YK; Mostafavi E; Kaushik A
Pharm Res; 2022 Nov; 39(11):2831-2855. PubMed ID: 35552983
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
13. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Treatment of Lung Cancer: Nanoparticle-based Drug and siRNA Delivery Systems.
Gencer A; Duraloglu C; Ozbay S; Ciftci TT; Yabanoglu-Ciftci S; Arica B
Curr Drug Deliv; 2021; 18(2):103-120. PubMed ID: 32748745
[TBL] [Abstract][Full Text] [Related]
15. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
16. Lipid-based Nanocarriers Loaded with Taxanes for the Management of Breast Cancer: Promises and Challenges.
Chaurawal N; Misra C; Raza K
Curr Drug Targets; 2022; 23(6):544-558. PubMed ID: 34431461
[TBL] [Abstract][Full Text] [Related]
17. Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.
Yang M; Gu Y; Tang X; Wang T; Liu J
Curr Drug Deliv; 2019; 16(4):312-324. PubMed ID: 30657039
[TBL] [Abstract][Full Text] [Related]
18. Strategies for drug targeting in pancreatic cancer.
Sharma N; Arora V
Pancreatology; 2022 Nov; 22(7):937-950. PubMed ID: 36055937
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer: active therapeutic targeting and inhalational nanoproduct design.
Alhajj N; Chee CF; Wong TW; Rahman NA; Abu Kasim NH; Colombo P
Expert Opin Drug Deliv; 2018 Dec; 15(12):1223-1247. PubMed ID: 30422017
[TBL] [Abstract][Full Text] [Related]
20. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
Rao S; Prestidge CA
Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
